Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLO-ASC for Tendon Injury
NCT02298023Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2014
- Primary completion
- Jul 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CSCC_ASC in rotator cuff tear (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change of Pain During Activity at 3 months. Started Sep 2014; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT02298023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298023.